Functionalized Positive Nanoparticles Reduce Mucin Swelling and Dispersion by Chen, Eric Y. T. et al.
Functionalized Positive Nanoparticles Reduce Mucin
Swelling and Dispersion
Eric Y. T. Chen
., Yung-Chen Wang
., Chi-Shuo Chen, Wei-Chun Chin*
Bioengineering, University of California Merced, Merced, California, United States of America
Abstract
Multi-functionalized nanoparticles (NPs) have been extensively investigated for their potential in household and commercial
products, and biomedical applications. Previous reports have confirmed the cellular nanotoxicity and adverse inflammatory
effects on pulmonary systems induced by NPs. However, possible health hazards resulting from mucus rheological
disturbances induced by NPs are underexplored. Accumulation of viscous, poorly dispersed, and less transportable mucus
leading to improper mucus rheology and dysfunctional mucociliary clearance are typically found to associate with many
respiratory diseases such as asthma, cystic fibrosis (CF), and COPD (Chronic Obstructive Pulmonary Disease). Whether
functionalized NPs can alter mucus rheology and its operational mechanisms have not been resolved. Herein, we report that
positively charged functionalized NPs can hinder mucin gel hydration and effectively induce mucin aggregation. The
positively charged NPs can significantly reduce the rate of mucin matrix swelling by a maximum of 7.5 folds. These NPs
significantly increase the size of aggregated mucin by approximately 30 times within 24 hrs. EGTA chelation of indigenous
mucin crosslinkers (Ca
2+ ions) was unable to effectively disperse NP-induced aggregated mucins. Our results have
demonstrated that positively charged functionalized NPs can impede mucin gel swelling by crosslinking the matrix. This
report also highlights the unexpected health risk of NP-induced change in mucus rheological properties resulting in
possible mucociliary transport impairment on epithelial mucosa and related health problems. In addition, our data can serve
as a prospective guideline for designing nanocarriers for airway drug delivery applications.
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Introduction
A myriad of functionalized-NPs have been used to develop
commercial commodities in various industrial sectors. They are
heavily implemented in the manufacturing of paint, carpet, paper,
plastic, textiles, clothes and cosmetics [1,2,3,4]. NPs also play
major roles in decontaminating aqueous wastes and food
processing [4,5,6]. Recent developments in the pharmaceutical
field focus on nanocarriers that transport drugs or genes to
targeted areas via inhalation to treat numerous respiratory and
systemic diseases [7,8]. The pulmonary route proves to be an
important site of nano-drug (e.g. aerosolized nanopowder) and
therapeutic gene delivery that offers both local and systemic
targeting for treatment of many diseases [8,9]. Even in major
respiratory diseases, such as pulmonary tuberculosis, cystic fibrosis
(CF), Chronic Obstructive Pulmonary Disease (COPD) and
bronchial asthma, nanocarriers have shown promising therapeutic
effects in vitro and in animal experiments [9,10].
Due to their diverse applications, recurrent aerosolized
exposure to these NPs are anticipated, yet the potential health
risks brought about by NPs are not fully understood [11].
Epidemiological studies have confirmed a positive correlation
between levels of particulate pollution and increased morbidity
and mortality rates among general populations [12,13]. The
adverse health effects seem to be dominated by pulmonary
symptoms. For instance, many reports have addressed that
occupational exposure of inhaled NPs can lead to respiratory
diseases such as pneumoconiosis (pulmonary fibrosis) and
bronchitis [14,15]. Increasing inhalation of ambient ultrafine
particles has been linked with exacerbation of respiratory
symptoms and mortality among COPD sufferers [16,17,18]. It
has also been documented that NPs can instigate oxidative stress
and cellular toxicity in various types of cells [8,19]. For instance, in
human bronchial epithelial cells, we have previously demonstrated
that titanium dioxide NP exposure resulted in cell death without
photoactivation [1]. In addition, polystyrene NPs have been shown
to induce lung inflammation [20].
Mucus rheology plays a critical role in maintaining respiratory
health. Mucins are large, highly glycosylated proteins [21,22]. The
polyanionic nature of mucin stems primarily from sialic acid,
sulfate, and carboxyl (COO
-) groups present in these linked
oligosaccharides. Beside physical entanglement, cationic calcium
ions can act as crosslinkers that condense the mucin matrices
inside mucin granules before exocytosis [22]. Upon release, phase
transition mainly driven by the Donnan effect triggers the massive
decondensation of mucin networks [22]. Hydrogen bonding,
hydrophilic and hydrophobic interactions have also been proposed
to contribute to the gel properties of mucin [22]. The gel
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maintaining the integrity of epithelia by trapping bacteria and
viruses for mucociliary clearance.
The clinical manifestation of major respiratory diseases (i.e.
COPD [23], asthma [24] and CF [25]) are related to thick mucus.
The relationship between mucin dehydration and defective mucus
clearance has been well established [26,27,28]. As a result, the
poorly hydrated, highly viscous and less transportable mucus
appears to accumulate within airway passages [24,29]. Obstruc-
tion of airway lumen with viscous mucus is usually accompanied
by chronic bacterial infection, inflammation and impaired
mucociliary transport [23,29]. Chronic exposure to NPs can
potentially predispose humans to lung inflammation and increase
the risk of COPD [18,30]. However, whether NPs can alter the
viscoelastic property of mucus and lead to concomitant patholog-
ical outcomes is not clear. Despite evidence on NP-induced
cellular nanotoxicity, studies addressing the link between the
surface property of NPs and their harmful effects are still lacking.
Our research examined the relationship between NP surface
modifications and alteration in mucus rheological properties. The
concentration range of NPs used in this investigation was within
the level found in ambience and in nanotechnology industries
[20,31]. In this study, we found that positively-charged NPs can
promote mucin aggregation, thereby reducing the rate of mucin
gel expansion via crosslinking polyanionic mucin matrices. Our
results provide the first mechanistic link between NP exposure and




The human lung carcinoma cell line A549 was obtained from
American Type Culture Collection (ATCC, VA, USA). A549 cell
line is an airway epithelial cell line commonly used as a secretory
model [32]. Cells were cultured in 15 cm cell culture plates (VWR,
CA, USA) containing F-12 nutrient mixture medium (Invitrogen,
CA, USA) that was supplemented with 100 U of penicillin/
streptomycin and 10% heat-inactivated fetal bovine serum (FBS)
(Invitrogen, CA, USA). The A549 lung cells were cultured in
15 cm Falcon plates and incubated in a humidified incubator at
37uC/5% CO2. Cell counts were performed using trypan blue
(Sigma-Aldrich, MO, USA) exclusion and a Bright-Line haemo-
cytometer.
Nanoparticle preparation
Carboxyl-, amine- and non-functionalized polystyrene particles
with various sizes (i.e. 57 nm, 99 nm, 120 nm and 160 nm) (Bangs
Laboratories, Fishers, IN, USA) were used in our study. All NPs
have a size standard deviation of #10% (based on manufacturer
information). These sizes were independently confirmed using
homodyne dynamics laser scattering. All nanoparticle samples
were sonicated before usage.
Particle sizing using dynamic laser scattering
The aggregation of mucus was monitored by measuring particle
size using homodyne dynamics laser scattering (DLS). Samples of
porcine gastric mucin at 1 mg/L (Sigma-Aldrich, MO, USA) were
prepared with Hanks’ solution containing 1.2 mM Ca
2+,2 0m M
Tris-HCl (tris(hydroxymethyl)aminomethane hydrochloride) and
10 mM MES (2-(N-morpholino)ethanesulfonic acid) (Sigma-Al-
drich, MO, USA) to buffer the pH around 7.4 [33]. The solution
was thoroughly mixed until mucin has dissolved. Aliquots of mucin
samples (10 ml) were directly filtered through a 0.22-mm Millipore
PES membrane (pre-washed with 0.1 N HCl) (Fisher Scientific,
CA, USA) into clean scintillating vials. The scintillating vials were
positioned in the goniometer of a Brookhaven laser spectrometer
(Brookhaven Instruments, NY, USA). Mucin gel aggregation was
allowed to take place by equilibrating with three filtered types of
NPs each expressing different surface modifications for 72 hrs;
they were subsequently analyzed by detecting the scattering
fluctuations at a 45 degree scattering angle. Commercialized
polystyrene NPs (Bangs Laboratories, Fishers, IN) with dimensions
of 57, 99, 120 and 160 nm were added to mucin samples. Positive
(-NH2 based, 57 and 160 nm), negative (-COOH, 120 nm) and
non-functionalized (hydrophobic, 99 nm) surface charges were
used in this study. All NPs were prepared in suspension of Hanks’
solution (buffered with Tris-HCl/MES at pH 7.4). Filtered NP
solution, added to scintillating vials, was tested for its ability to
promote mucin aggregation and was monitored at 1 hr, 3 hrs,
5 hrs, 24 hrs, 48 hrs and 72 hrs. Self aggregation induced by NP-
only and mucin-only controls were monitored at 1 hr, 24 hrs,
48 hrs and 72 hrs. The pH was also monitored and maintained at
approximately 7.4 during the experiments. The autocorrelation
function of the scattering intensity fluctuations was averaged over
a 3-min sampling time using a Brookhaven BI 9000AT
autocorrelator. Particle size distribution was calculated by
CONTIN [34]. Calibration was conducted with standard
monodisperse suspensions of latex microspheres ranging from
50 nm to 10 mm (Polysciences, PA, USA).
Scanning electron microscopy (SEM)
Samples of porcine gastric mucin at 1 mg/L (Sigma-Aldrich,
MO, USA) were prepared with Hanks’ solution (buffered with
Tris-HCl/MES at pH 7.4) and incubated with 10 mg/L of
positively-charged 57 and 160 nm NPs. After incubation for
5 hrs or 72 hrs, 5 ml of mucin were filtered through a 0.22-mm
Millipore isopore membrane (Fisher Scientific, CA, USA). The
filtered mucin was subsequently fixed with 4% paraformaldehyde
(prepared in PBS at pH 7.4) (Sigma-Aldrich, MO, USA) for
5 min, followed by careful rinsing with Hanks’ solution twice. The
fixed mucin and NP complexes were dehydrated by soaking in
serially diluted ethanol (35%, 50%, 70%, 95% and 100% ethanol)
for 5 min. The specimens were air dried and examined with FEI
Quanta 200 ESEM (North America NanoPort, OR, USA).
EGTA dispersion of aggregated mucin
EGTA (Ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tet-
raacetic acid, 2 mM) (Sigma-Aldrich, MO, USA) was used to
disperse aggregated mucus, which was monitored by measuring
particle size by homodyne dynamics laser scattering. Samples of
porcine gastric mucin at 1 mg/L (Sigma-Aldrich, MO, USA) were
prepared with Hanks’ solution containing 1.2 mM Ca
2+ (buffered
with Tris-HCl/MES at pH 7.4) and thoroughly mixed until mucin
has dissolved. Aliquots of mucin samples (10 ml) were directly
filtered through a 0.22-mm Millipore PES membrane (pre-washed
with 0.1 N HCl) (Fisher Scientific, CA, USA) into clean
scintillating vials. The scintillating vials were positioned in the
goniometer of a Brookhaven laser spectrometer (Brookhaven
Instruments, NY, USA). Mucin gel aggregation was initiated by
incubating mucin samples with filtered positively-charged NPs (-
NH2 based 57 and 160 nm) (Bangs Laboratory Inc, Fishers, IN)
and were monitored after 1, 3, 5, 24, 48 and 72 hrs. EGTA
(2 mM) was subsequently applied to already aggregated mucin
solution after 72 hrs. The change in aggregation size was detected
for another 72 hrs. The pH was also monitored and maintained at
approximately 7.4 during the experiments. The autocorrelation
function of the scattering intensity fluctuations was averaged over
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autocorrelator. Particle size distribution was calculated by the
CONTIN [34]. Calibration was conducted with standard
monodisperse suspensions of latex microspheres ranging from
50 nm to 10 mm (Polysciences Inc, PA, USA).
Swelling kinetics of exocytosed mucin matrices
The A549 cell culture plates were rinsed with Hanks’ buffer
twice. Non-trypsin dissociation buffer (Invitrogen, CA, USA) was
added to detach cells from the plates and were subsequently
incubated at 37uC for 15 minutes, centrifuged at 700 rpm for
5 min, and resuspended in Hanks’ solution (Invitrogen, CA, USA)
(buffered with Tris-HCl/MES at pH 7.4). Cells were resuspended
into MatTek glass bottom dishes (MatTek Corporation, MA,
USA) and equilibrated in a 37uC incubator for 10 minutes prior to
adding 10 mg/L and 1 mg/L of 160 and 57 nm positively-
charged NPs (Bangs Laboratories, Fishers, IN). The pH was
monitored and maintained at approximately 7.4 throughout the
experiments.
A549 cells were viewed and video-recorded with phase-contrast
lens using a Nikon Eclipse TE-2000-U inverted fluorescence
microscope (Nikon Eclipse TE-2000U, Tokyo, Japan). Degranu-
lation of A549 cells was induced by 1 uM ionomycin (Sigma-
Aldrich, MO, USA) and was found to be a readily observable
discrete quantal process. During exocytosis into extracellular
Hanks’ solution, released granule matrices undergo rapid swelling.
Video-recordings of granular exocytosis and swelling were
captured at 30 frames s
21.
Measurements of radii, of the released mucin matrices, as a
function of time were used to verify that the swelling of the
secreted material followed the characteristic features of polymer
gel swelling kinetics [35,36]. The swelling of a polymer gel follows
a typical diffusive kinetics that is independent of the size, internal
topology, or chemical composition of the gel [36]. For spherical
gels as observed from the exocytosed mucin granule matrices of
A549 cells, the radial dimension increased following a character-
istic first order kinetics of the form r(t)=rf–(rf–ri)e
–t/t (equation 1),
where ri and rf are the initial and final radius of the secretory
granule matrix, respectively, and t is the characteristic relaxation
time of the swelling process [22]. The polymer network of gels




21]) (equation 2). The diffusivity (D) of polyionic
gels varied with the concentration of counterions in the swelling
medium.
Statistical Analysis
The data was presented as means6SD. Each experiment was
performed independently at least three times. Statistical signifi-
cance was determined using a Student’s t-test analysis with p
values of ,0.005 (Microsoft Excel and GraphPad Prism 4.0,
GraphPad Software, Inc., San Diego, CA, USA).
Results
Positively-charged nanoparticle induces mucin
aggregation
To understand the possible mechanisms of how surface charge
modifications on NPs affect mucin rheological properties, we
examined the effect of different NP surface charges on mucin
aggregation and gelation. NPs with non-functionalized, positive, or
negative surface charges were added to mucin samples to monitor
the mucin gel size change with dynamic laser scattering (DLS)
after 0, 1, 3, 5, 24, 48 and 72 hrs. DLS is a well established
technique used to measure the hydrodynamic diameter of mucin
gel aggregates [37]. In Figure 1A, it is clearly demonstrated that a
steady concentration-dependent increase in mucin aggregate size
was induced by positively-charged amine (-NH2) polystyrene NPs
(160 nm) at 1 mg/L and 10 mg/L. Positively-charged NPs (1 mg/
L) caused mucin to aggregate from the original 240 nm to
1000 nm within 24 hrs and plateaued throughout 72 hrs. In
comparison to the NP-only control (no mucin) at 1 mg/L, only
minor aggregation was found throughout the 72 hrs (Figure 1D).
On the other hand, 10 mg/L of positively-charged NPs induced a
quick rise in mucin aggregation starting from the 1
st hour
(,2000 nm) to the 5
th hour (,2900 nm). At the 24
th hour, the
average mucin gel size increased rapidly to around 5500 nm,
while it plateaued around 72 hrs at 6300 nm (Figure 1A).
Comparing the 10 mg/L treatment group to the mucin-only
control (Figure 1G), there is a 19 and 24 time increase in mucin
aggregate size in the corresponding 24 and 72 hrs. However, at
much lower concentrations, positively-charged NPs (100 mg/L)
failed to induce significant mucin aggregation (Figure 1A). In
addition, multiple concentrations of negatively-charged (-COOH
based, 120 nm) and non-functionalized (99 nm) NPs yielded a
basal size of about 200 nm (Figures 1B & C). The results show that
negatively-charged and non-functionalized NPs are not able to
associate effectively with mucins (Figures 1B & C). Therefore, our
data showed that only positively-charged NPs can effectively
promote mucin aggregation. A NP size-dependent effect on mucin
aggregation was subsequently investigated. Figure 1E illustrated
positively-charged 57 nm NPs generated more pronounced mucin
aggregates than 160 nm under the same conditions. The control
experiment (Figures 1D & F) indicated that 10 mg/L of 160 and
57 nm positive charged NPs generated only slight self-clumping.
Furthermore, 57 nm NP-induced mucin aggregates were approx-
imately 30 times larger than the mucin-only control (Figures 1E &
G). The mucin-only control remained at the hydrodynamic
diameter of about 200 nm throughout 72 hrs (Figure 1G). These
results suggested that NP-induced mucus aggregation occurred
mainly as a result of the interactions between NPs and mucin
instead of self-aggregation of NPs or mucins.
SEM images of nanoparticles-induced mucin gel complex
To provide a visual representation that further establishes the
relationship between NP concentrations and the size of mucin gels,
aggregated mucin size was determined by SEM images. Mucin
samples containing 10 mg/L of 57 nm and 160 nm positively-
charged NPs were prepared. The resulting mucin gels were
collected at 5 hrs and 72 hrs. Mucin gels were filtered through
0.22 mm Isopore membranes, fixed and imaged with SEM. Sizes
of mucin aggregates presented in Figures 2A–D confirm the size
measurements from DLS. It is also evident that longer incubation
resulted in larger NP-mucin aggregates for 57 nm NPs (Figures 2B
& D) and 160 nm NPs (Figures 2A & C), which is consistent with
DLS measurements (Figures 1A & E). In addition, SEM images
demonstrated that these aggregated mucin gels were associated
with NPs forming NP-mucin gel complexes.
Positively-charged nanoparticles serve as mucin gel
crosslinkers
Calcium ions have been shown to act as a vital crosslinker in the
formation, stability and condensation of mucin gels [22]. Our
previous results have shown that gels crosslinked by Ca
2+ can be
dispersed by Ca
2+ chelators (e.g. EDTA) [34]. To further
understand the role that positively-charged NPs play in promoting
mucin aggregation and gelation, we tested whether positively-
charged NPs can serve as crosslinkers replacing Ca
2+ ions.
Positively-charged NPs (10 mg/L) of 160 nm and 57 nm were
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PLoS ONE | www.plosone.org 3 November 2010 | Volume 5 | Issue 11 | e15434Figure 1. Interaction of NPs and mucin aggregation. (A) Positively-charged NPs (160 nm) (n$6) induce significant mucin aggregation while (B)
negatively-charged (120 nm) (n$6) and (C) non-functionalized NPs (99 nm) (n$6) fail to induce mucin aggregation since the aggregate size
remained below 300 nm throughout 72 hrs incubation. (D) Positively-charged NPs (160 nm) (n$5) alone can not generate large aggregates in the
same Hanks’ solution. Smaller size positively-charged (57 nm) (n$6) promote larger mucin aggregates (E). At the same time, negative controls show
that (F) positively-charged NPs (57 nm) (n$5) or (G) mucin alone (1 mg/L, n$5) can not generate large aggregates. Various concentrations (solid
circles: 100 mg/L, solid triangles: 1 mg/L, solid squares: 10 mg/L) of positively-charged, negatively-charged and non-functionalized NPs (160, 57, 120
and 99 nm) were added to mucin solution (1 mg/L). Significant mucin aggregates were found at 10 mg/L and 1 mg/L of positive NPs. The size of
mucin-NPs aggregates were determined with DLS as described previously [37].
doi:10.1371/journal.pone.0015434.g001
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applying 2 mM EGTA (Ca
2+ chelator). The pH was kept in a
range of pH 7.4 by Tris-HCl and MES. The changes of
aggregated mucin size were subsequently monitored after 3, 24,
48, and 72 hrs. Figures 3A & B demonstrated that calcium
chelation by EGTA was unable to significantly reduce aggregated
mucin size caused by 160 nm or 50 nm NPs. This result further
supports the role of positively-charged NPs as Ca
2+ crosslinkers.
Positively-charged nanoparticles retards mucin hydration
rate
Knowing that positively-charged NPs can disturb mucin
rheological properties, we then tested whether positively-charged
NPs could impair mucin hydration by utilizing an in vitro mucin
swelling kinetics functional assay (see methods). A representative
graph comparing the swelling kinetics of newly exocytosed mucin
networks, between the control and positively-charged NP
treatment, is shown in Figure 4A. The evidence indicated that
positively-charged NPs impeded the swelling rate (,hydration) of
mucin networks (Figure 4A). Converting swelling rate into
diffusivity (D) using equation (2) yielded similar results. The
measurements showed that positively-charged NPs (10 mg/L) of
160 and 57 nm retarded the rates of mucin diffusivity approxi-
mately 3.6 and 7.5 times, while 1 mg/L of 160 and 57 nm
decreased mucin diffusivity about 1.7 and 6.1 times, correspond-
ingly, when compared to the control (NP free) (Figure 4B). Within
the same category of NP size, there is also a concentration-
dependent effect on reducing the rate of mucin diffusivity. Higher
NP concentration (10 mg/L) yields a slower rate of mucin
diffusivity than lower NP concentration (1 mg/L). Our data
indicates that positively-charged NPs can reduce the rates of
mucin hydration and diffusivity, possibly leading to an elevated
mucus viscosity and dysfunctional mucociliary transport.
Discussion
Mucus is mainly composed of large and heavily glycosylated
glycoproteins called mucin. The gel-forming mucins rapidly
hydrate after exocytosis and due to their tangle network
properties, anneal with other mucins to form a protective barrier
at the airway-surface liquid layer. The mucin gel layer lines the
epithelial surface of various organs such as the vaginal tract, eyes,
gastric wall and pulmonary lumen [38]. Mucus in the airway of
l u n g ss e r v e sa sa ni n n a t ei m m u n ed e f e n s ea g a i n s ti n h a l e d
Figure 2. SEM images of mucin-NP complexes. SEM micrographs of mucin-NPs complexes with 160 nm (A, C) and 57 nm (B, D) positively-
charged NPs after 5 hrs (A, B) and 72 hrs (C, D). There SEM images clearly demonstrate that NPs and mucins aggregate together forming large mucin-
NPs gels. The black holes in the images are the pores in Isopore membranes. The scale bar is 1 mm.
doi:10.1371/journal.pone.0015434.g002
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protection mechanism stems from the delicate balance between
normal mucus production, transport and clearance. The mucin
polymer network of mucus has a characteristic tangled topology
[40]. Since the rheological properties of mucus are governed
mainly by the tangle density of mucin polymers, which decreases
with the square of the volume of the mucin matrix, the mucin
network hydration (degree of swelling) is the most critical factor in
determining the rheological properties of mucus [22]. The
diffusivity of mucin matrices, which is closely related to mucin
viscosity [22,36], can be calculated from polymer swelling
kinetics. Based on the polymer network theory, polymer
diffusivity is inversely proportional to its viscosity [41,42,43].
Thus, lower rate of mucin diffusivity is associated with higher
viscosity, less dispersed and less transportable mucins that appear
to characterize the clinical symptoms of thick mucus accumula-
tion and obstruction commonly found in asthma, COPD and CF
[29,35,44]. Although chronic exposure to NPs has been shown to
induce excessive mucin synthesis [45] and increase the risk of
Figure 3. Inability of EGTA (Ca
2+ chelator) to disperse NPs-
induced mucin aggregates. Positively-charged NPs with sizes of
160 nm (A) and 57 nm (B) at 10 mg/L induced mucin (1 mg/L) to
aggregate forming large size mucin-NPs aggregates (,6 mm) in 72 hrs
(n$6). EGTA (2 mM) was added to chelate Ca
2+ ions that can crosslink
mucins forming gels. However, EGTA can not disperse mucin-NPs
aggregates after 72 hrs incubation.
doi:10.1371/journal.pone.0015434.g003
Figure 4. Effects of NPs on swelling kinetics and diffusivity of
secretory granule matrix. (A) Data points of swelling kinetics of
secretory granule matrices of A549 cells were fit with equation (1).
Exocytosis was triggered by ionomycin. Two representative lines are
displayed here. The control (NP free; open circles) shows a higher rate of
swelling of newly released mucin network than the swelling rate of
mucin matrix when exposed to positively-charged NP (160 nm, 1 mg/L,
solid circle). The black arrows indicate the swelling of exocytosed mucin
matrix at different time points. (B) Positively-charged NPs hinder the
rate of mucin diffusivity (hydration). Mucin post-exocytotic swelling
from A549 cells was significantly reduced by positively- charged NPs
(160 and 57 nm). This protocol to estimate mucin diffusivity of newly
released mucin gels from A549 cells was adapted from our previous
study [65]. Data are shown as mean6SD (n$10). NP treated groups are
significantly different from the untreated control at p,0.005 as
indicated by *.
doi:10.1371/journal.pone.0015434.g004
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viscous mucus has not been explored.
Due to the versatile application of NPs in nanocarrier delivery
systems and commercial products, NPs with varying surface
functionalization and characteristics are widely utilized [9,46].
The polyanionic nature of mucin glycoproteins allows for possible
electrostatic interactions with oppositely charged NPs. In this
study, we investigated how surface charges and size modifications
of NPs influence mucus rheological properties. Mucus hydration
can be significantly impeded by a change in electrolyte
concentration in airway-surface liquid (ASL) [22]. Calcium ion
concentration has been shown to increase from 1 mM to 4 mM in
the ASL of CF patients, hindering proper mucus swelling and
hydration [47] and leading to respiratory health problems. So far
there is no evidence documenting ASL abnormalities in NP-
induced airway diseases. However, the mechanism by which NPs
can cause changes in the rheological properties of mucus is still
unknown.
Gastric mucin was used as a model mucin in our investigation as
it shares many similarities with airway mucins [48,49,50]. Our
approach is consistent with previous studies that used gastric
mucin to examine the viscoelastic properties and biological
applications of mucins [51,52,53,54,55,56], since there is currently
no commercial mucin sample available that can be preserved in
the native state. We utilized DLS to probe the interactions
between functionalized NPs and mucin. DLS is a common
technique implemented to measure the Brownian motion of mucin
polymer in solvent [21,22]. One of the major advantages of this
technique is that it enables mucin structure and dynamics to be
examined in the native state without chemical fixation, which
minimizes protein denaturation and artifacts [21,22]. The
diffusion constant that was calculated from Brownian motion
measurement is inversely proportional to the hydrodynamic
diameter of the measured particle; low diffusion constant usually
correlates with large mucin gelation/aggregation [21,22]. As
demonstrated by Figures 1A, E & 2A–D, positively-charged NPs
can promote mucin aggregation (NP-mucin gel complexes) in a
concentration- and size-dependent manner. The mechanism may
involve electrostatic attraction between positively-charged NPs
and the polyanionic sites on mucin such as the sialic, sulfate and
carboxyl functional groups promoting mucin aggregation. By the
same notion, mucin polyanionic charges are neutralized by
cationic calcium counterions [22] which condenses the mucin
matrix and facilitates gel formation [57,58]. On the other hand,
negatively-charged and non-functionalized NPs failed to generate
significant mucin aggregation. Other studies have shown that
hydrophobic and mucin-mucin interactions play vital roles in pH-
induced gelation of gastric mucin [59]. However, the hydrophobic
moieties on non-functionalized NPs failed to promote significant
mucin gelation in our study. This inability might be partially due
to the low mucin concentration (1 mg/L) and the neutral pH
(buffered at 7.4). The negatively-charged NPs are likely to repel
anionic sialic, sulfate and carboxyl functional groups on mucin
thereby hindering mucin aggregation [21,22]. Another possible
mechanism could be that these negatively-charged NPs can
chelate divalent ions (e.g. Ca
2+) in the solution, which play a
critical role in mucin gel crosslinking [22].
In addition, our data validated that smaller NPs can induce the
formation of larger size mucin aggregated gels more effectively
(Figures 1E, 2B & D). The resulting larger mucin gels can possibly
be elucidated by differential charge densities on NPs [60]. Our
findings are supported by other studies showing that positively-
charged chitosan coated NPs, or amine-modified NPs, were highly
adhesive to polyanionic mucus gels [61,62]. Viral particles with
highly dense positive charges have also been proposed to be more
mucoadhesive [38].
After establishing that positively-charged NPs can promote
mucin gelation, our data suggests that positively-charged NPs may
indeed act as network crosslinkers. Figures 3A & B confirmed that
EGTA chelation of indigenous mucin network crosslinker Ca
2+
ions was unable to disperse the NP-induced mucin aggregation/
gelation. Therefore, positively-charged NPs crosslink the poly-
anionic tangle networks via electrostatic interactions. This
evidence further validates the idea that positively-charged NPs
effectively replace the natural role of Ca
2+ ions and highlights the
health danger with irreversibly strengthening the crosslinking
within mucin gels.
To demonstrate the harmful consequence that positively-
charged NPs can have through their crosslinking ability on mucus
rheological properties, a swelling kinetics functional assay was
used. We determined the direct effect of positively-charged NPs on
the mucus hydration rate by measuring the swelling kinetics of
newly exocytosed mucin matrices from human lung A549 cells
under positively-charged NP exposure. A549 cells are a represen-
tative in vitro model system for studying mucin swelling kinetics as
they express both major respiratory MUC 5AC and MUC 5B
mucin proteins [63,64]. Our study showed that positively-charged
NPs hindered the rates of mucin matrix hydration and diffusivity
in both a concentration- and size-dependent manner (Figures 4A
& B). In accordance with the polymer network theory (lower
diffusivity correlates with higher viscosity) [41,42,43], our data
indicated that positively-charged NPs decrease the rate of mucin
diffusivity and can increase the viscosity of mucin network; the
effect of which is further enhanced by smaller sized NPs. Our
experimental data has provided the first mechanistic link between
positively-charged NPs and altered rheological properties of
mucus.
Conclusions
The positively-charged NPs can crosslink mucins, thus forming
NP-mucin gel complexes. The effects of which can potentially
induce the formation of viscous mucus and hinder proper mucus
hydration and dispersion, leading to impaired mucociliary
transport in various epithelial mucosa. The outcome of viscous
mucus accumulation could exacerbate pulmonary symptoms of
diseased individuals and potentially elevate chances of morbidity
in healthy pulmonary systems [23]. As in the case of COPD, CF,
or asthma patients, positively-charged NPs could worsen the
problem by further thickening the mucus. The complications may
include additional reduction in the airway flow or the promotion
of chronic bacterial infection. This report also indicates some
possible undesirable side effects of drug delivery using positively-
charged nanocarriers via epithelial mucosa. These NPs might lead
to drug entrapment within mucus, impedance of proper mucus
dispersion, and transportability. Our study also found that non-
functionalized and negatively-charged NPs have less impact on the
rheological properties of mucus. This finding provides the
necessary knowledge needed for the safety consideration when
using positively-charged functionalized NPs.
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